Page 1/18 Promising Use of Filgotinib in Patients Affected by Systemic Sclerosis: Preliminary Data From a Monocentric, Prospective, Open-label Study Gilda Sandri Scleroderma Unit, Chair of Rheumatology, University of Modena and Reggio Emilia Marco de Pinto (  marcodepinto1993@gmail.com ) Scleroderma Unit, Chair of Rheumatology, University of Modena and Reggio Emilia Amelia Spinella Scleroderma Unit, Chair of Rheumatology, University of Modena and Reggio Emilia Pierluca Macripò Scleroderma Unit, Chair of Rheumatology, University of Modena and Reggio Emilia Gabriele Amati Scleroderma Unit, Chair of Rheumatology, University of Modena and Reggio Emilia Federica Lumetti Scleroderma Unit, Chair of Rheumatology, University of Modena and Reggio Emilia Ottavio Secchi Scleroderma Unit, Chair of Rheumatology, University of Modena and Reggio Emilia Anna Guerra Internal Medicine and Centre for Hemochromatosis, University Hospital of Modena, University of Modena and Reggio Emilia Dilia Giuggioli Scleroderma Unit, Chair of Rheumatology, University of Modena and Reggio Emilia Article Keywords: Posted Date: July 5th, 2023 DOI: https://doi.org/10.21203/rs.3.rs-3100614/v1 License:   This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Additional Declarations: No competing interests reported.